Obese patients with type I diabetes
OtherPostsurgical follow - up in obese patients with type I diabetes
NCT Number: NCT02612493
Obesity is the indication for bariatric surgery in type I diabetes. Interestingly postsurgery the patients improve remarkable in their need for insulin, not only in the daily total insulin dosage but also in the dosage of IU per kg.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
The investigators performed a retrospective analysis on 16 patients undergoing weight loss surgery in obesity with concomitant type I diabetes. All patients were evaluated during Follow - Up to analyze insulin dosage and metabolic changes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Postsurgical follow - up in obese patients with type I diabetes
Time frame: up to 8 years
Insulin dosage postsurgery
Time frame: up to 8 years
Time frame: up to 8 years
Time frame: up to 8 years
Sana Klinikum Offenbach
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04279613
Autoimmune Diseases, Diabetes Mellitus
Orange, California, United States
View Trial DetailsNCT06674135
Autoimmune Diseases, Diabetes Mellitus
Dhaka, Bangladesh
View Trial DetailsNCT06242548
Activity, Motor, Autoimmune Diseases
Chambéry, Cente Hospitalier Métropole Savoie, France
View Trial DetailsNCT05151770
Autoimmune Diseases, Diabetes Mellitus
Marseille, France
View Trial Details